G. Bandoli et al., SOLID-STATE STRUCTURES AND CONFORMATIONAL STUDIES OF 4 1,2,3,4-TETRAHYDROACRIDINE ALZHEIMERS-DISEASE THERAPEUTICS, Journal of chemical crystallography, 24(5), 1994, pp. 301-310
The solid-state structures of four 1,2,3,4-tetrahydroacridines [tacrin
e hydrochloride monohydrate (1), 7-methoxytacrine hydrochloride monohy
drate (2), velnacrine hydrogenmaleate (3) and suronacrine hydrogenmale
ate (4)] were determined from single-crystal X-ray diffraction analysi
s. (1): monoclinic, P2(1)/n, a = 8.778(1), b = 8.521(1), c = 17.603(2)
angstrom, beta = 101.34(1)-degrees. (2): monoclinic, C2/c, a = 12.326
(7), b = 18.050(9), c = 13.822(8) angstrom, beta = 113.70(4)-degrees.
(3): triclinic, P1BAR, a = 7.349(2), b = 9.417(3), c = 12.557(4) angst
rom, alpha = 109.62(2), beta = 98.12(2), gamma = 101.18(2)-degrees. (4
): monoclinic, P2(1)/n, a = 8.513(6), b = 18.74(1), c = 13.401(6) angs
trom, beta = 91.21(5)-degrees. Final R factors for compounds (1)-(4) a
re 0.047, 0.057, 0.057, 0.11, respectively. The overall arrangement of
the common aminotetrahydroacridine skeleton looks similar in all deri
vatives. However, whereas enantiomerization of the unsubstituted cyclo
hexenyl rings occurs in (1) and (2), only quasi-axially hydroxyl subst
ituted diastereomers are found for (3) and (4). This is presumably due
to the different propensities for hydrogen bonding of axially vs. equ
atorially disposed hydroxyl groups with the hydrogenmaleate anions. Em
pirical and semiempirical calculations were performed to examine the c
onformational behavior of the four compounds, both in vacuo and in sol
ution.